Katharina is CEO and Founder of OccamzRazor, an organization using computational drug discovery to create a cure for neurodegenerative diseases. She was Stanford's first Ph.D. in Stem Cell Biology and Regenerative Medicine, which she achieved in record time, and was listed in MIT’s 35 under 35 innovators and Forbes’ 30 under 30.